{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:58:32Z","timestamp":1787169512654,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To assess the outcome and response of transcutaneous retrobulbar injection of amphotericin B (TRAMB) in post-coronavirus disease of 2019 (COVID-19) rhino-orbito-cerebral mucormycosis (ROCM) and to establish a scoring system in guiding treatment modalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An interventional, prospective study was done on 82 eyes of post-COVID-19 ROCM from May 2021 to July 2021. A comprehensive multi-departmental evaluation along with detailed ophthalmic examination, laboratory investigations, and radiological examination was done. Scoring points were given to each symptom, sign, and radiological features of orbit and the total score was taken. Based on these scores, severity of disease was grouped into A, B, and C corresponding to mild, moderate, and severe orbital ROCM. One milliliter of reconstituted liposomal amphotericin B was given to all patients every alternate day as three doses. Efficacy of these injections was assessed in all groups, even though other treatment modalities like orbital debridement and exenteration were considered for moderate and severe cases. Patients were followed up for a period of 8 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of 82 eyes, symptomatic improvement was seen in a major proportion (72%) of patients. A statistically significant improvement in scores was noted in group A (93% improved) with a\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value of 0.002, while 68.4% showed improvement in group B (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value- 0.0001). Group C with severe disease showed minimal improvement in post-injection scores of 41% (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      -value 0.086), necessitating surgical intervention. No serious adverse effect of the drug or procedure was noted.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Significant improvement in scores of groups A and B highlights TRAMB as an effective and safe treatment modality in mild to moderate ROCM. It is an effective adjunct in severe cases, along with other interventions. Also, the scoring system helps in assessing the severity and guiding in management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2356_21","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T08:01:36Z","timestamp":1645776096000},"page":"1019-1024","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience"],"prefix":"10.4103","volume":"70","author":[{"given":"Lakshmi B","family":"Ramamurthy","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ridhi","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savitha","family":"Kanakpur","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Thejaswini","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.4103\/ijo.IJO_1165_21","article-title":"Code Mucor: Guidelines for the diagnosis, staging and management of rhino-orbito-cerebral mucormycosis in the setting of COVID-19","volume":"69","author":"Honavar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B2-20240828","article-title":"Outcomes of a modified treatment ladder algorithm using retrobulbar amphotericin B for invasive fungal rhino-orbital sinusitis","author":"Ashraf","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.4103\/ijo.IJO_3763_20","article-title":"COVID-19 and orbital mucormycosis","volume":"69","author":"Sarkar","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/IOP.0000000000000806","article-title":"Retrobulbar injection of amphotericin B for orbital mucormycosis","volume":"33","author":"Hirabayashi","year":"2017","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/ICU.0000000000000394","article-title":"Invasive fungal sinusitis: Treatment of the orbit","volume":"28","author":"Kalin-Hajdu","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/IOP.0000000000000488","article-title":"The role of adjunctive therapies in the management of invasive sino-orbital infection","volume":"31","author":"Colon-Acevedo","year":"2015","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/ijo.IJO_3774_20","article-title":"Mucor in a viral land: A tale of two pathogens","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4103\/ijo.IJO_1565_21","article-title":"Epidemiology, clinical profile, management, and outcome of COVID-19-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India \u2013 Collaborative OPAI-IJO study on mucormycosis in COVID-19-19 (COSMIC), Report 1","volume":"69","author":"Sen","year":"2021","journal-title":"Indian J Opthalmol"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/bjophthalmol-2015-306945","article-title":"Invasive fungal disease of the sinus and orbit: A comparison between mucormycosis and Aspergillus","volume":"100","author":"Trief","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00002341-199901000-00007","article-title":"Role of local amphotericin B therapy for sinoorbital fungal infections","volume":"15","author":"Seiff","year":"1999","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/01676830.2021.1960382","article-title":"Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients","volume":"40","author":"Nair","year":"2021","journal-title":"Orbit"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0022215111001289","article-title":"Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B","volume":"125","author":"Saedi","year":"2011","journal-title":"J Laryngol Otol"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1155\/2015\/458670","article-title":"Trichosporon asahii infection after total knee arthroplasty: A case report and review of the literature","volume":"26","author":"Zuo","year":"2015","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"B14-20240828","first-page":"608","article-title":"Adjuvant intrapleural amphotericin B therapy for pulmonary mucormycosis in a cardiac allograft recipient","volume":"11","author":"Kfoury","year":"1997","journal-title":"Clin Transplant"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002341-198909000-00012","article-title":"Orbital aspergillosis. Conservative debridement and local amphotericin irrigation","volume":"5","author":"Harris","year":"1989","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1128\/IAI.73.2.778-783.2005","article-title":"Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro","volume":"73","author":"Ibrahim","year":"2005","journal-title":"Infect Immun"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12070-018-1293-8","article-title":"orbital exenteration in rhino-orbito-cerebral mucormycosis: A prospective analytical study with scoring system","volume":"71","author":"Shah","year":"2019","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.73.5.397","article-title":"Amphotericin B induced ocular toxicity in cryptococcal meningitis","volume":"73","author":"Li","year":"1989","journal-title":"Br J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2356_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:07:25Z","timestamp":1787166445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2356_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2356_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"assertion":[{"value":"2021-09-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}